In recent years, there has been an increasing focus on the role of LAMs in various types of leukemia, including acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), and chronic myeloid leukemia (CML) (9, 41–44). Here, LAMB2 is linked to acute lymphoblastic leukemia.